BackSkye Bioscience Overview

Skye Bioscience Long Term Debt

Track Skye Bioscience's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
↓ 100.00% YoYΔ $-223.47M vs prior year quarter

Peer average

Loading

Skye Bioscience Long Term Debt History

Loading

Skye Bioscience vs. peers: Long Term Debt Comparison

Loading

Skye Bioscience Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Skye Bioscience (SKYE) FAQ

Skye Bioscience (SKYE) currently reports a long-term debt of $0 as of March 2026. That compares with $220M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Skye Bioscience's long-term debt history and peer comparisons.

Skye Bioscience's long-term debt decreased from $220M to $0 — a 100.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Skye Bioscience reported $0 in long-term debt as of March 2026. That compares with $220M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Skye Bioscience, and consider following SKYE for alerts when major investors trade the stock.